388 related articles for article (PubMed ID: 689037)
1. Interaction of human blood platelets with the 2',3'-dialdehyde and 2',3'-dialcohol derivatives of adenosine 5'-diphosphate and adenosine 5'-triphosphate.
Pearce PH; Wright JM; Egan CM; Scrutton MC
Eur J Biochem; 1978 Aug; 88(2):543-54. PubMed ID: 689037
[TBL] [Abstract][Full Text] [Related]
2. Factors influencing the response of human blood platelets to analogues of ADP which may act as partial agonists at the ADP receptor.
Egan CM; Fisher AP; Scrutton MC
Eur J Biochem; 1979 Mar; 95(1):127-37. PubMed ID: 110586
[TBL] [Abstract][Full Text] [Related]
3. Shape change and aggregation of blood platelets: interaction between the effects of adenosine and diphosphate, 5-hydroxytryptamine and adrenaline.
Michal F; Motamed M
Br J Pharmacol; 1976 Feb; 56(2):209-18. PubMed ID: 1252669
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of adenine nucleotide analogues on shape change and aggregation induced by adnosine 5-diphosphate (ADP) in human platelets.
Park HS; Hourani SM
Br J Pharmacol; 1999 Jul; 127(6):1359-66. PubMed ID: 10455285
[TBL] [Abstract][Full Text] [Related]
5. Platelet activation by 2-(4-bromo-2,3-dioxobutylthio)adenosine 5'-diphosphate is mediated by its binding to a putative ADP receptor, aggregin.
Puri RN; Colman RF; Colman RW
Eur J Biochem; 1996 Mar; 236(3):862-70. PubMed ID: 8665907
[TBL] [Abstract][Full Text] [Related]
6. Adrenaline and adenosine diphosphate-induced platelet aggregation require shape change. Importance of pseudopods.
Milton JG; Frojmovic MM
J Lab Clin Med; 1984 Nov; 104(5):805-15. PubMed ID: 6387013
[TBL] [Abstract][Full Text] [Related]
7. Effects of analogues of adenine nucleotides on increases in intracellular calcium mediated by P2T-purinoceptors on human blood platelets.
Hall DA; Hourani SM
Br J Pharmacol; 1993 Mar; 108(3):728-33. PubMed ID: 8467360
[TBL] [Abstract][Full Text] [Related]
8. The effects of ATP on platelets: evidence against the central role of released ADP in primary aggregation.
Macfarlane DE; Mills DC
Blood; 1975 Sep; 46(3):309-20. PubMed ID: 167888
[TBL] [Abstract][Full Text] [Related]
9. ADP induces partial platelet aggregation without shape change and potentiates collagen-induced aggregation in the absence of Galphaq.
Ohlmann P; Eckly A; Freund M; Cazenave JP; Offermanns S; Gachet C
Blood; 2000 Sep; 96(6):2134-9. PubMed ID: 10979958
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of ADP-induced platelet shape change and aggregation by o-phthalaldehyde: evidence for covalent modification of cysteine and lysine residues.
Puri RN; Colman RW
Arch Biochem Biophys; 1991 May; 286(2):419-27. PubMed ID: 1910292
[TBL] [Abstract][Full Text] [Related]
11. Nucleoside triphosphates inhibit ADP, collagen, and epinephrine-induced platelet aggregation: role of P2Y₁ and P2Y₁₂ receptors.
Aslam M; Sedding D; Koshty A; Santoso S; Schulz R; Hamm C; Gündüz D
Thromb Res; 2013 Nov; 132(5):548-57. PubMed ID: 24071464
[TBL] [Abstract][Full Text] [Related]
12. Effects of antimycin and 2-deoxyglucose on adenine nucleotides in human platelets. Role of metabolic adenosine triphosphate in primary aggregation, secondary aggregation and shape change of platetets.
Holmsen H; Setkowsky CA; Day HJ
Biochem J; 1974 Nov; 144(2):385-96. PubMed ID: 4462589
[TBL] [Abstract][Full Text] [Related]
13. Studies on the effects of agonists and antagonists on platelet shape change and platelet aggregation in whole blood.
Sanderson HM; Heptinstall S; Vickers J; Lösche W
Blood Coagul Fibrinolysis; 1996 Mar; 7(2):245-8. PubMed ID: 8735830
[TBL] [Abstract][Full Text] [Related]
14. Secretory mechanisms. Behaviour of adenine nucleotides during the platelet release reaction induced by adenosine diphosphate and adrenaline.
Holmsen H; Day HJ; Setkowsky CA
Biochem J; 1972 Aug; 129(1):67-82. PubMed ID: 4675006
[TBL] [Abstract][Full Text] [Related]
15. Effects of the P2-purinoceptor antagonist, suramin, on human platelet aggregation induced by adenosine 5'-diphosphate.
Hourani SM; Hall DA; Nieman CJ
Br J Pharmacol; 1992 Feb; 105(2):453-7. PubMed ID: 1559134
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of ADP-induced aggregation of human platelets by beta, gamma-methylene-ATP.
Evans PM
Cytobios; 1978; 23(90):101-8. PubMed ID: 158489
[TBL] [Abstract][Full Text] [Related]
17. A possible dual physiological role of extracellular ATP in the modulation of platelet aggregation.
Soslau G; Youngprapakorn D
Biochim Biophys Acta; 1997 Feb; 1355(2):131-40. PubMed ID: 9042333
[TBL] [Abstract][Full Text] [Related]
18. Deficiency of (33P)2MeS-ADP binding sites on platelets with secretion defect, normal granule stores and normal thromboxane A2 production. Evidence that ADP potentiates platelet secretion independently of the formation of large platelet aggregates and thromboxane A2 production.
Cattaneo M; Lombardi R; Zighetti ML; Gachet C; Ohlmann P; Cazenave JP; Mannucci PM
Thromb Haemost; 1997 May; 77(5):986-90. PubMed ID: 9184415
[TBL] [Abstract][Full Text] [Related]
19. Inhibition by a stable analogue of adenosine triphosphate of platelet aggregation by adenosine diphosphate.
Born GV; Foulks JG
Br J Pharmacol; 1977 Sep; 61(1):87-9. PubMed ID: 912211
[TBL] [Abstract][Full Text] [Related]
20. Rat platelet aggregation by ATP. Aggregometrical and ultrastructural comparison with aggregations induced by ADP and collagen.
Ts'ao C
Am J Pathol; 1976 Dec; 85(3):581-94. PubMed ID: 998732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
